MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DIAGNOSTIC MARKERS AND FEATURES OF PHARMACOTHERAPY
Article PDF

Keywords

multisystem inflammatory syndrome, children

Abstract views: 49
PDF Downloads: 21

How to Cite

КhaitovychM., Voroniuk, L., Borisova, G., Diudenko, N., & Miagka, N. (2021). MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN: DIAGNOSTIC MARKERS AND FEATURES OF PHARMACOTHERAPY. Medical Science of Ukraine (MSU), 17(1), 24-28. https://doi.org/10.32345/2664-4738.1.2021.03

Abstract

Relevance. In 2020, children were hospitalized with fever and multisystem inflammation throughout the world during the COVID-19 pandemic. In the United States, this condition is called MIS-C (Multisystem Inflammatory Syndrome in Children). This syndrome is thought to be similar to the severe course of COVID-19 in adults (cytokine storm).

The objective of the work is to evaluate the features of the course and pharmacotherapy of multisystem inflammatory syndrome in children.

Materials and methods. The study included 17 children (10 boys and 7 girls) aged 3-16 years (on average – 9.5±3.4 years). Diagnosis of coronavirus infection was performed by polymerase chain reaction with real-time detection, determined the level of immunoglobulins M and G before coronavirus infection.

Results. The duration of fever in patients was 5-21 days (average 8.1±4.0 days), the duration of inpatient treatment – 7-35 days (average 15.7±7.0 days). Blood albumin levels were reduced in 53.8% of children; the level of fibrinogen was increased in 88.2% of children, the level of C-reactive protein, ferritin, and D-dimer – in all patients. 15 (88.2%) children had pathology of the digestive system, 13 (76.5%) – cardiovascular system (7 children were diagnosed with carditis, 2 – dilation of coronary arteries, 7 – cardiac arrhythmia). Acute respiratory distress -syndrome was found in a 13-year-old girl, shock - in an 11-year-old boy, 11 children (64.7%) were diagnosed with the pathology of the respiratory system (pleurisy, pneumonia), skin and mucous membranes, and 4 children (23.5%) there were manifestations of central nervous system disorders (meningism, decreased reflexes, ataxia), in 2 (11.8%) – renal failure. On average, each patient had lesions of 3.9 ±1.2 systems.

Conclusions. MIS-C was manifested by prolonged fever, high levels of laboratory markers of inflammation, hypoalbuminemia, hypercoagulation, often – pathological manifestations of the cardiovascular, digestive, respiratory systems, skin, and mucous membranes. The treatment included intravenous immunoglobulin, steroids, anticoagulant, and antibacterial therapy and was effective.

https://doi.org/10.32345/2664-4738.1.2021.03
Article PDF

References

Ahmed M., Advani S., Moreira A., Zoreti S., Martinez J. et al. Multisystem inflammatory syndrome in children: A systematic review. EClinicalMedicine. 2020 Sep 01; 26: 100527. DOI: 10.1016/j.eclinm.2020.100527.

View at: Publisher Site: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(20)30271-6/fulltext

Scholar: https://scholars.uthscsa.edu/en/publications/multisystem-inflammatory-syndrome-in-children-a-systematic-review

Europe PMC: https://europepmc.org/article/med/32923992

Borkotoky R.K., Barua P.B., Paul S.P., Heaton P.A. COVID-19-related Potential Multisystem Inflammatory Syndrome in Childhood in a Neonate Presenting as Persistent Pulmonary Hypertension of the Newborn. Pediatr Infect Dis J. 2021 Jan 12. Online ahead of print. DOI: 10.1097/inf.0000000000003054

View at: Publisher Site: https://journals.lww.com/pidj/Abstract/9000/COVID_19_related_Potential_Multisystem.95900.aspx

PubMed: https://pubmed.ncbi.nlm.nih.gov/33464010/

Europe PMC: https://europepmc.org/article/med/33464010

Esposito S., Principi N. Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2. Paediatr Drugs. 2021 Jan 22; 1-11. Online ahead of print. DOI: 10.1007/s40272-020-00435-x.

View at: Publisher Site: https://link.springer.com/article/10.1007%2Fs40272-020-00435-x

Fouriki A., FougèreY., De Camaret C., Rohner G.B., Grazioli S., Wagner N. et al. Case Report: Case Series of Children With Multisystem Inflammatory Syndrome Following SARS-CoV-2 Infection in Switzerland. Front Pediatr. 2021 Jan 5; 8: 594127. DOI: 10.3389/fped.2020.594127.

View at: Publisher Site: https://www.frontiersin.org/articles/10.3389/fped.2020.594127/full

PubMed: https://pubmed.ncbi.nlm.nih.gov/33469522/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7813982/

Gupta S., Chopra N., Singh A., Gera R., Chellani H. Pandey R., Arora B.S. Unusual Clinical Manifestations and Outcome of Multisystem Inflammatory Syndrome in Children (MIS-C) in a Tertiary Care Hospital of North India. J Trop Pediatr. 2021 Jan 29; 67(1): fmaa127. DOI: 10.1093/tropej/fmaa127

View at: Publisher Site: https://academic.oup.com/tropej/article-abstract/67/1/fmaa127/6123399?redirectedFrom=fulltext

PubMed: https://pubmed.ncbi.nlm.nih.gov/33513240/

Europe PMC: https://europepmc.org/article/med/33513240

Kest H., Kaushik A., DeBruin W., Colletti M., Goldberg D. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with 2019 Novel Coronavirus (SARS-CoV-2) Infection. Case Reports in Pediatrics. 2020. 2020: Article ID 8875987, 4 pages. DOI: 10.1155/2020/8875987

View at: Publisher Site: https://www.hindawi.com/journals/cripe/2020/8875987/

PubMed: https://pubmed.ncbi.nlm.nih.gov/32733733/

PubMed Central: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383305/

Kwak J.H., Lee S.-Y., Choi J.-W. Korean Society of Kawasaki Disease. 2020. Clinical features, diagnosis, and outcomes of multisystem inflammatory syndrome in children associated with coronavirus disease. 2019. Clinical and Experimental Pediatrics 2021; 64(2): 68-75. DOI: 10.3345/cep.2020.01900

View at: Publisher Site: https://www.e-cep.org/journal/view.php?doi=10.3345/cep.2020.01900

PubMed: https://pubmed.ncbi.nlm.nih.gov/33445833/

PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7873390/

Europe PMC: https://europepmc.org/article/med/33445833

Mehra B., Aggarwal V., Kumar P., Kundal M., Gupta D., Kumar A. et al. COVID-19-associated Severe Multisystem Inflammatory Syndrome in Children with Encephalopathy and Neuropathy in an Adolescent Girl with the Successful Outcome: An Unusual Presentation. Indian J Crit Care Med. 2020; 24(12): 1276-8. DOI: 10.5005/jp-journals-10071-23685

View at: Publisher Site: https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-23685

PubMed: https://pubmed.ncbi.nlm.nih.gov/33446986/

PubMed Central: https://www.ncbi.nlm.nih.gov/research/coronavirus/publication/33446986

Müller J., Oberhoffer R., Brudy L., Ewert P. COVID-19 and paediatric patient involvement (cardiovascular aspects). Eur Heart J Suppl. 2020 Dec 23; 22(Suppl Pt t): P19-P24. DOI: 10.1093/eurheartj/suaa168

View at: Publisher Site: https://academic.oup.com/eurheartjsupp/article/22/Supplement_P/P19/6046108

PubMed: https://pubmed.ncbi.nlm.nih.gov/33390865/

PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7757714/

Europe PMC: https://europepmc.org/article/med/33390865

Mustafa M.R., Carter M.J., Wong J., Bell A., Salih C. Coronary aneurysms, myocardial dysfunction, and shock in a COVID-19 child, role of ECMO, immunomodulation, and cardiac CT. Cardiol Young. 2021 Jan 28; 1-5. DOI: 10.1017/s1047951121000147

View at: Publisher Site: https://www.cambridge.org/core/journals/cardiology-in-the-young/article/abs/coronary-aneurysms-myocardial-dysfunction-and-shock-in-a-covid19-child-role-of-ecmo-immunomodulation-and-cardiac-ct/49B5F4C159FB2FDE1D63B9C30C1C085D

PubMed: https://pubmed.ncbi.nlm.nih.gov/33504377/

Europe PMC: https://europepmc.org/article/med/33504377

Navaeifar M. R., Shahbaznejad L., Lotfabadi A.S., Rezai M.S. COVID-19-Associated Multisystem Inflammatory Syndrome Complicated with Giant Coronary Artery Aneurysm. Case Rep Pediatr. 2021; 2021: Article ID 8836403. DOI: 10.1155/2021/8836403

View at: Publisher Site: https://www.hindawi.com/journals/cripe/2021/8836403/

Schvartz A., Belot A., Kone-Paut I. Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases During SARS-CoV-2 Pandemic. Front Pediatr. 2020; 8: 605807. DOI: 10.3389/fped.2020.605807.

View at: Publisher Site: https://www.frontiersin.org/articles/10.3389/fped.2020.605807/full

PubMed: https://pubmed.ncbi.nlm.nih.gov/33344389/

PubMed Central: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7746854/

Europe PMC: https://europepmc.org/article/med/33344389

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.